Cannabis Central: Pure-Play Pot Stock Portfolio Performance For Monday, August 31st

The munKNEE.com Pure-Play Pot Stock Portfolio consists of the 25 pure-play* cannabis stocks that trade for more than US$1/share and it advanced 0.3% on Monday. 10 participants went UP, 13 went DOWN and 2 had no change in price. In addition, 3 of the 4 industry categories advanced. The details are as follows:

Major Winners

Only 2 stocks advanced by 5% or more, namely:

1. Greenlane (GNLN) +15.4% following a -31.1% move on Friday
2. Valens (VLNCF) +5.6%

8 other stocks went up by less than 5% and 2 stocks had no change in price.

Major Losers

Only 2 stocks declined by 5% or more, namely:

1. cbdMD (YCBD) -8.9% on top of a -17.9% on Friday
2. Medicine Man (SHWZ) -5.3%

11 other stocks declined by less than 5% in price.

The 25 munKNEE Pure-Play Pot Stock Portfolio participants operate in 4 categories based on their primary area of focus in the cannabis industry. The stocks within each category are identified below with how they did, on average, within each category:

1. The Vertically Integrated (i.e. Seed-to-Sale) Category has 21 portfolio participants that grow, process, and sell cannabis and hemp flower and related products and they went UP .05%, on average.
   • the 7 Canadian Licensed Producer (LPs) portfolio participants  (ACB; APHA; CGC; CRON; OGI; ROMJF and TLRY) went    DOWN 0.5%, on average.
   • the 12 U.S. Multi-State Operator (MSOs) portfolio participants (ACRGF; AYRSF; CCHWF; CRLBF; CURLF; GTBIF; HRVSF; JUSHF; PLNHF; SHWZ; TCNNF and TRSSF) went UP 0.7%, on average.
   • the 2 hemp seed-to-sale MSO portfolio participants (CWBHF and YCBD) went DOWN 4.6%, on average.
2. The Extraction Category has 2 portfolio participants (NEPT and VLNCF) focused on the extraction of cannabis compounds and their infusion into consumer products and they went UP 0.2%, on average.
3. The Consumption Devices Category has only 1 portfolio participant  (GNLN) focused on developing and selling personal consumption devices for cannabis consumers such as vape pens and inhalers and it went UP 15.4% after having gone DOWN 31.1% on Friday.
4. The Biotechnology Category has only 1 portfolio participant (AVCNF) which markets new drugs utilizing cannabinoids (CBD) and it went  DOWN 1.0%.

*Please note: The 25 pure-play stocks in the munKNEE.com Pure-Play Pot Stock Portfolio are just that, pure, deriving 100% of their revenue from the sale of recreational and medicinal cannabis and consumption-related products so as to reflect the true health of the marijuana industry in the U.S. and Canada.